Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
# robots.txt for nerlynx.com User-agent: * Disallow: /404 Disallow: /500 Sitemap: |
Title | Reducing |
Description | Home Learn about NERLYNX® (neratinib) tablets and the risk of recurrence in patients with HER2+ breast cancer. See safety/patient info on |
Keywords | N/A |
WebSite | nerlynx.com |
Host IP | 40.112.243.46 |
Location | United States |
Site | Rank |
US$11,234,286
Last updated: 2023-05-10 11:00:26
nerlynx.com has Semrush global rank of 942,143. nerlynx.com has an estimated worth of US$ 11,234,286, based on its estimated Ads revenue. nerlynx.com receives approximately 1,296,264 unique visitors each day. Its web server is located in United States, with IP address 40.112.243.46. According to SiteAdvisor, nerlynx.com is safe to visit. |
Purchase/Sale Value | US$11,234,286 |
Daily Ads Revenue | US$10,371 |
Monthly Ads Revenue | US$311,104 |
Yearly Ads Revenue | US$3,733,240 |
Daily Unique Visitors | 86,418 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
nerlynx.com. | A | 599 | IP: 40.112.243.46 |
nerlynx.com. | NS | 3600 | NS Record: ns34.domaincontrol.com. |
nerlynx.com. | NS | 3600 | NS Record: ns33.domaincontrol.com. |
Product Information For Healthcare Professionals Home Understanding HER2+ breast cancer What is HER2+ breast cancer? What’s the difference between early-stage and metastatic HER2+ breast cancer? Right now, why should I worry about my cancer coming back? Where does NERLYNX fit in my treatment plan? NERLYNX and you How does NERLYNX work? NERLYNX in women with early-stage and metastatic HER2+ breast cancer Tips for taking NERLYNX How do I manage side effects? Working with your healthcare team Support for you and your family Working with your healthcare team Become an advocate in your care Puma Patient Lynx: NERLYNX education and support programs Puma Patient Lynx: Support programs to help make NERLYNX accessible Get started... See resources that may help you start and stay with NERLYNX. Learn more Reduce your risk... In a clinical trial, NERLYNX reduced the risk of cancer returning for people with early-stage HER2+ breast cancer after trastuzumab-based therapy. Learn more about NERLYNX |
HTTP/1.1 301 Moved Permanently Content-Length: 0 Content-Type: text/html; charset=UTF-8 Location: https://nerlynx.com/ Date: Tue, 02 Nov 2021 16:22:55 GMT HTTP/1.1 200 OK Cache-Control: public, max-age=0 Content-Length: 35143 Content-Type: text/html; charset=UTF-8 Last-Modified: Fri, 17 Sep 2021 18:23:42 GMT Accept-Ranges: bytes ETag: W/"8947-17bf4fffc15" X-Powered-By: Express Date: Tue, 02 Nov 2021 16:22:56 GMT |
Domain Name: NERLYNX.COM Registry Domain ID: 1944481099_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2021-07-05T13:08:15Z Creation Date: 2015-07-04T12:40:31Z Registry Expiry Date: 2022-07-04T12:40:31Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS33.DOMAINCONTROL.COM Name Server: NS34.DOMAINCONTROL.COM DNSSEC: unsigned >>> Last update of whois database: 2021-09-22T08:24:18Z <<< |